Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

Fig. 1

Correlations between baseline biomarkers. CRP, C-reactive protein; CXCL13, chemokine (C-X-C motif) ligand 13; Lp(a), lipoprotein (a); MMP-3, matrix metalloproteinase-3; OPG, osteoprotegerin; P1NP, procollagen type 1 N-terminal propeptide; RANKL, receptor activator of nuclear factor-κB ligand; SAA, serum amyloid A; sICAM-1, soluble intercellular adhesion molecule-1; TIBC, total iron-binding capacity

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us